- Home
- ANGI vs TECX Comparison
ANGI vs TECX Comparison
Compare ANGI & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGI
- TECX
- Stock Information
- Founded
- ANGI 1995
- TECX 2019
- Country
- ANGI United States
- TECX United States
- Employees
- ANGI N/A
- TECX N/A
- Industry
- ANGI Advertising
- TECX
- Sector
- ANGI Consumer Discretionary
- TECX
- Exchange
- ANGI Nasdaq
- TECX Nasdaq
- Market Cap
- ANGI 916.3M
- TECX 746.6M
- IPO Year
- ANGI 2017
- TECX 2018
- Fundamental
- Price
- ANGI $14.70
- TECX $16.84
- Analyst Decision
- ANGI Buy
- TECX Strong Buy
- Analyst Count
- ANGI 7
- TECX 5
- Target Price
- ANGI $30.83
- TECX $77.75
- AVG Volume (30 Days)
- ANGI 430.1K
- TECX 240.2K
- Earning Date
- ANGI 05-06-2025
- TECX 03-20-2025
- Dividend Yield
- ANGI N/A
- TECX N/A
- EPS Growth
- ANGI N/A
- TECX N/A
- EPS
- ANGI 0.70
- TECX N/A
- Revenue
- ANGI $1,185,112,000.00
- TECX N/A
- Revenue This Year
- ANGI N/A
- TECX N/A
- Revenue Next Year
- ANGI $3.67
- TECX N/A
- P/E Ratio
- ANGI $21.00
- TECX N/A
- Revenue Growth
- ANGI N/A
- TECX N/A
- 52 Week Low
- ANGI $14.63
- TECX $1.40
- 52 Week High
- ANGI $29.20
- TECX $61.07
- Technical
- Relative Strength Index (RSI)
- ANGI 38.07
- TECX 28.67
- Support Level
- ANGI $15.30
- TECX $20.35
- Resistance Level
- ANGI $17.37
- TECX $23.06
- Average True Range (ATR)
- ANGI 0.93
- TECX 1.97
- MACD
- ANGI -0.02
- TECX -0.00
- Stochastic Oscillator
- ANGI 3.58
- TECX 3.18
About ANGI Angi Inc.
Angi Inc connects quality home service professionals across different categories, from repairing and remodeling to cleaning and landscaping, with consumers. The Company has three operating segments namely, Ads and Leads that generate maximum revenue, Services, and International (Europe and Canada). The company operates under multiple brands that including Angi, HomeAdvisor, and Handy. The majority of the revenue is earned from the United States.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.